These findings have potential applications in the treatment of CLE as the effect of Resveratrol mimics the inhibition of proinflammatory cytokines such as TNF-α and IFN-α seen in the antimalarials that are currently used in treating SLE and CLE (Alves et al., 2017). Here, IFNA1 is linked to systemic lupus erythematosus.